Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)

NCT03821610 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT03821610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03821610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Complete Remission. (ALL-RIC)
Lead sponsor
University of Birmingham
Phase
Phase 2
Overall status
Active, not recruiting
Start date
November 22, 2018
Completion date
November 22, 2027
Enrollment
242 (estimated)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia